Skip to content

Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study

Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04264325
Acronym
ADD-Echo
Enrollment
15
Registered
2020-02-11
Start date
2020-01-31
Completion date
2023-05-03
Last updated
2023-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, Malignant Pleural Effusion

Keywords

Dyspnea, Malignant pleural effusion, Lung Neoplasms, Therapeutic thoracocentesis, Lung ultrasound, Diaphragmatic ultrasound, Diaphragmatic dysfunction

Brief summary

Malignant pleural effusions cause breathlessness and impairs quality of life. Thoracocentesis is frequently used to relieve breathlessness. The severity of breathlessness correlates poorly with the size of the effusion. Symptom reduction from fluid drainage varies between patients. No predictors exist to identify which patients benefits more of pleural effusion. One study suggests that a inverted hemidiaphramatic (inverted shape) is associated with a greater dyspnea improvement. Others parameters of diaphragmatic motion have not been studied till now. This study aims to evaluate the feasability of diaphragmatic ultrasound evaluation (shape by B-mode, quiet, deep inspiratory motion and sniff diaphragm motion by TM-mode) before and after pleural drainage. Primary end point aims to evaluate the feasability of deep breath inspiratory excursion in ipsilateral side of thoracocentesis by anterior subcostal approach in the mid-clavicular line in the right in patients with malignant pleural effusions. The liver or spleen was identified as a window for each hemidiaphragm. Secondary end points aim to evaluate * the feasability of quiet breath inspiratory motion , * the feasability of sniff diaphragm motion * the feasability of deep breath inspiratory motion by posterior method * the comparaison of feasibility with different types of breathing and or anterior or posterior approach for ultrasound * the feasability of the shape by B-mode. * the correlation between the change of the shape of ipsilateral diaphragm and the evolution of dyspnea, before and after thoracocentesis. * the correlation between the volume of pleural effusion evacuated and the evolution of dyspnea, before and after thoracocentesis. * the comparaison of the changing of dyspnea in patients with noticed paradoxal movement of diaphragm before thoracocentesis and patients with persistent paradoxal/or non persistant paradoxal movement of ipsilateral hémidiaphragm. * the correlation between the feasability of diaphragmatic ultrasound motion measurments evaluation and the body mass index. * the comparaison between the different diaphragmatic ultrsound times for anterior or posterior approach.

Interventions

OTHERdiaphragmatic ultrasound measure

patients with lung neoplasms and malignant pleural effusions who need a diagnostic or therapeutic thoracocentesis

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age\> 18 years old * Male or female patient * Patient with known lung cancer, regardless of histology or suspected of having unknown lung cancer or relapse / progression of lung cancer * Presenting a pleural effusion with clinical necessity of evacuating pleural puncture * Subject who expressed his non opposition to the research

Exclusion criteria

* Patient's refusal to participate in the study * History of pleurodesis whatever the indication (pneumothorax or recurrent pleural effusion) or the technique used * Permanent chest drain * inability to provide informed information to the subject (subject in an emergency, difficulty understanding the subject, etc.) * Subject under judicial protection * Subject under guardianship or curatorship * Pregnant or lactating woman

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the feasibility of measuring the diaphragmatic amplitude in wide breathing (RA) on the side homolateral to the pleural punctureone dayRate of patients with a feasible measure of diaphragmatic amplitude in wide breathing (RA), on the side homolateral to the pleural puncture, by the anterior route before and after pleural puncture.

Secondary

MeasureTime frameDescription
Feasability of quiet breath inspiratory motionone dayRate of patients with a feasible measure of diaphragmatic amplitude in spontaneous breathing (RS), on the side homolateral to the pleural puncture, by the anterior route before and after pleural puncture.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026